Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06586671
What this trial is testing

Compare Forms of Nemtabrutinib (MK-1026) in Healthy Adult Participants (MK-1026-007)

Who this might be right for
Hematological Malignancy
Merck Sharp & Dohme LLC 40
Early research (Phase 1)Study completedNCT03048344
What this trial is testing

A Phase I, Two-part Study to Determine the Recommended Dose and Evaluate the Safety and Tolerability of a Novel Oral Arsenic Trioxide Formulation (ORH-2014) in Subjects With Advanced Hematological Disorders

Who this might be right for
Advanced Hematological Disorders
Orsenix LLC 12
Early research (Phase 1)Looking for participantsNCT07036133
What this trial is testing

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

Who this might be right for
Advanced Solid TumorsHematologic Malignancies
Acrotech Biopharma Inc. 24
Not applicableNot Yet RecruitingNCT06402175
What this trial is testing

Characteristics and Outcomes of Patients With Hematological Malignancies

Who this might be right for
Haematologic Neoplasm
Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT01474681
What this trial is testing

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

Who this might be right for
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Novartis Pharmaceuticals 27
Not applicableLooking for participantsNCT06253338
What this trial is testing

Optimization of Radiation Protection Through Genomic Analyses

Who this might be right for
DNACancerRadiation
University Hospital, Essen 30
Not applicableActive Not RecruitingNCT07251348
What this trial is testing

Progressive Relaxation and Psychoeducation in Patients With Hematological Malignancies

Who this might be right for
Hematological Cancer
Necmettin Erbakan University 75
Early research (Phase 1)Study completedNCT00743028
What this trial is testing

Assess the Oral Bioavailability of New ABT-263 Formulations

Who this might be right for
Chronic Lymphocytic LeukemiaLymphomasLeukemias
Abbott 36
Early research (Phase 1)Looking for participantsNCT06731699
What this trial is testing

FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS

Who this might be right for
AMLNHL
Chengdu FenDi Pharmaceutical Co., Ltd. 72
Not applicableNot Yet RecruitingNCT07162532
What this trial is testing

Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
Assiut University 45
Not applicableStudy completedNCT05549232
What this trial is testing

Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital

Who this might be right for
Hematologic NeoplasmsBurns
Hemanext 22
Large-scale testing (Phase 3)Looking for participantsNCT07007312
What this trial is testing

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Kura Oncology, Inc. 1,300
Not applicableLooking for participantsNCT06350994
What this trial is testing

Early Assessment of Cardiac Function After Treatment With CAR-T Cells

Who this might be right for
Car T- CellHematologic MalignancyAcute Lymphoblastic Leukemia+2 more
Assistance Publique - Hôpitaux de Paris 60
Not applicableLooking for participantsNCT06503380
What this trial is testing

Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer

Who this might be right for
Hematological ToxicityTargeted TherapyBreast Cancer
Fudan University 1,000
Not applicableUnknownNCT02213822
What this trial is testing

Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis

Who this might be right for
Solid TumorsHematological Malignancies
Rhode Island Hospital 500
Not applicableLooking for participantsNCT06699394
What this trial is testing

Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis

Who this might be right for
AL Amyloidosis
Peking University People's Hospital 20
Not applicableStudy completedNCT02562105
What this trial is testing

Prognosis of Hematological Cancer Patient Underwent Mechanical Ventillation

Who this might be right for
Hematological MalignancyAcute Respiratory FailureMechanical Ventilation
Mansoura University 50
Testing effectiveness (Phase 2)UnknownNCT00930566
What this trial is testing

Extracorporal Photopheresis Pilot Study

Who this might be right for
Hematological Malignancies
Hospices Civils de Lyon 20
Not applicableNot Yet RecruitingNCT07145359
What this trial is testing

Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation

Who this might be right for
Cancer and / or Hematological MalignancyHematopoetic Stem Cell TransplantationNursing Interventions+3 more
Halic University 30
Early research (Phase 1)Study completedNCT01317927
What this trial is testing

Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies

Who this might be right for
Solid TumorHematological Malignancy
Spectrum Pharmaceuticals, Inc 27
Next Page